Entrepreneurial CEO for ChARM
We’re building a venture that develops a more dependable method for diagnosing pneumonia in children in low-resource environments.
ChARM is an automated breath counter that accurately measures respiratory rate in children. It provides significantly more reliable results than manual and other automated techniques, enabling fast and accurate pneumonia diagnosis by community health workers or clinics. The device is available in both non-rechargeable and rechargeable versions, making it suitable for settings with- or without the ability to recharge the device. The device is ready for the market and has been supported by extensive clinical research. The next steps involve developing a successful go-to-market strategy and setting up collaborations with partners, such as prominent NGOs.
The position of CEO
The CEO will be responsible for developing and executing the overall business and commercial strategy, actively supported by NLC The Healthtech Venture Builder and partnering with The Phillips Foundation and other strategic partners.
Dilutive and non-dilutive fundraising.
Defining and executing a commercial strategy for the device to sell in low resource environments
Partnering with NGOs and distributors to bring the device to the patient in low resource settings
As CEO, lead the integrated venture including: Q&R, R&D, legal, and financial workstreams
You are highly motivated to make an impact on patients, have commercial success and bring the following characteristics, experience and network:
A proven track-record in commercialisation of medical devices in Low and Middle Income Countries
A connector with strong networking and influencing ability at all levels of seniority
Excellent communication skills, including presentation and negotiation skills
Have fundraising experience, both dilutive and non-dilutive
A strong network with leading NGOs and commercial distributors focused on providing healthcare to low resource settings
We offer the unique opportunity to an entrepreneur or executive with entrepreneurial ambition to come on board as a partner (essentially co-founder) in a highly promising venture. The participation package includes:
Cash compensation tied to successful funding of the company
The opportunity to Co-fund at a favourable valuation.
Access to the expertise and network of the entire NLC ecosystem including the use of NLC Venture Services.
Sparring and support from your Venture Partner and the dozens of CEO’s leading our other (100+) ventures.
Last but not least:
The CEO of ChARM should be eager to lead this venture because of the critical need for innovative solutions in diagnosing and treating pneumonia in resource-constrained areas. This device holds great potential to save the lives of children suffering from pneumonia.
For more information please contact Wijna Bekker — (NLC Venture Teaming) via [email protected]
To apply for this job please visit nlc.health.